GLP-compliant six-month toxicity and biodistribution study following single intravenous administration of ATA-200 for LGMDR5 treatment in Sprague-Dawley rats

ATA-200 - Atamyo Therap

https://pag.virtual-meeting.org/US/asgct2026/en-US/pag/presentation/685831

Estelle Creoff1; Laurine Buscara1; Sylvie Marchand1; Philippe Veron1; Jérome Poupiot1; Sophie Olivier2; Nathalie Daniele1; Adeline Guais-Vergne1; Gérald Perret1; Isabelle Richard1,2

Apr 13, 2026